A carregar...
Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.
BACKGROUND: The present report was commissioned as a supplement to an existing technology assessment report produced by the Peninsula Technology Assessment Group (PenTAG), which evaluated the clinical effectiveness and cost-effectiveness of dasatinib and nilotinib in patients who are either resistan...
Na minha lista:
| Publicado no: | Health Technol Assess |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
NIHR Journals Library
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4781455/ https://ncbi.nlm.nih.gov/pubmed/22564553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta16230 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|